title: Citalopram-induced Raynaud's phenomenon.
authors.affiliation: Clinical Pharmacology Unit, Hospital General de Alicante, c/Pintor Baeza s/n, 03010, Alicante, Spain. peiro_ana@gva.es
authors.forename: A M
authors.initials: AM
authors.lastname: Peiró
authors.forename: C
authors.initials: C
authors.lastname: Margarit
authors.forename: M
authors.initials: M
authors.lastname: Torra
mesh_terms: D000328:Adult; D000700:Analgesics / Q000627:therapeutic use; D015283:Citalopram / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009437:Neuralgia / Q000188:drug therapy / Q000523:psychology*; D011928:Raynaud Disease / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*
chemical_list: D000700:Analgesics; D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors